The tl;dr Pharmacy Journal Club: Fish Oil for Cardiovascular Risk Reduction in Hemodialysis Patients

Did you know that more than half of patients with end stage renal disease pass from cardiovascular events? Seems pretty crappy, to be honest. All that time spent on hemodialysis machines trying to help the kidneys do their job, and then the heart is (often quietly) suffering. So what can we do - if anything - to help? Let’s take a look at the PISCES trial.

Clinical, Pharmacy School, Practice, ResidencyStephanie KujawskiFebruary 10, 2026fish oil hemodialysis, PISCES trial study journal club, PISCES trial fish oil hemodialysis, HD cardiovascular mortality interventions, how to prolong life on hemodialysis, medications for dialysis patients